Transactions
May 4 2021
TripleTree Advises Icario on its Recapitalization by CVC Capital Partners
Icario, the healthcare industry’s leading health action company, is pleased to announce that CVC Capital Partners (“CVC”), a leading global private equity firm, has acquired a majority interest in the company through the CVC Growth Partners II fund. The investment will be used to fuel Icario’s next phase of growth.
LEAD INVESTMENT BANKERS
Icario, the healthcare industry’s leading health action company, is pleased to announce that CVC Capital Partners (“CVC”), a leading global private equity firm, has acquired a majority interest in the company through the CVC Growth Partners II fund. The investment will be used to fuel Icario’s next phase of growth.
LEAD INVESTMENT BANKERS
We prioritize your privacy. We do not sell your information and will only send occasional, relevant emails.
Copyright © 2024 TripleTree, LLC.
All Rights Reserved